Mobia Medical

Markets the Vivistim Paired Vagus Nerve Stimulation System, an implanted Class III device used with physical or occupational therapy to improve hand and arm motor function in adults with chronic ischemic-stroke impairment. Systems and accessories are sold to U.S. stroke hospitals, where implanting clinicians, therapists, referrals, and patient education must coordinate the care pathway.

Builds adoption through territory managers that establish hospital programs and licensed therapy-development specialists that educate rehabilitation sites, while registry and clinical work support coverage and guideline development. All revenue comes from the same product and United States market; demand depends on reimbursement, prior authorization, willingness to undergo implantation, ongoing FDA requirements, and single-source suppliers for critical implant components.